{"DataElement":{"publicId":"3117210","version":"1","preferredName":"Neoplasm Staging Performed Malignant Testicular Germ Cell Tumor Stage","preferredDefinition":"A description of the malignant testicular germ cell tumor stage.","longName":"3117127v1.0:3117205v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3117127","version":"1","preferredName":"Neoplasm Staging Performed","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The process of defining at what point in the natural history of a malignant disease a patient is when a diagnosis is made._Executed and carried through to completion.","longName":"3117124v1.0:2828214v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"3117124","version":"1","preferredName":"Neoplasm Staging","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C3262:C15608","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Staging","conceptCode":"C15608","definition":"The process of defining at what point in the natural history of a malignant disease a patient is when a diagnosis is made.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A69BE67-0896-523D-E040-BB89AD436C0B","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2241241","version":"1","preferredName":"Performed","preferredDefinition":"Performed; carried out.","longName":"C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FA7953-8839-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A69C74D-BB71-26B3-E040-BB89AD433CAC","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3117205","version":"1","preferredName":"Malignant Testicular Germ Cell Tumor Stage","preferredDefinition":"A malignant tumor predominantly affecting young men and often associated with cryptorchidism.  Seminoma is the most frequently seen malignant testicular germ cell tumor, followed by embryonal carcinoma and yolk sac tumor. -- 2004_Any distinct time period in a sequence of events.","longName":"3117205v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage III","valueDescription":"stage III","ValueMeaning":{"publicId":"3117206","version":"1","preferredName":"stage III","longName":"3117206","preferredDefinition":"the cancer involves the testis and metastasus beyond the retroperitoneal and paraaortic lymph nodes","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A6A557F-FF49-CF56-E040-BB89AD431AD8","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A6A557F-FF62-CF56-E040-BB89AD431AD8","beginDate":"2010-07-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"},{"value":"Stage II","valueDescription":"stage II","ValueMeaning":{"publicId":"3117207","version":"1","preferredName":"stage II","longName":"3117207","preferredDefinition":"cancer involved the testis and metastasis to retroperitoneal / paraaortic lymph nodes","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A6A557F-FF6C-CF56-E040-BB89AD431AD8","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A6A557F-FF85-CF56-E040-BB89AD431AD8","beginDate":"2010-07-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"},{"value":"Stage I","valueDescription":"stage I","ValueMeaning":{"publicId":"3117208","version":"1","preferredName":"stage I","longName":"3117208","preferredDefinition":"cancer remains localized to the testis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A6A557F-FF8F-CF56-E040-BB89AD431AD8","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A6A557F-FFA8-CF56-E040-BB89AD431AD8","beginDate":"2010-07-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3117204","version":"1","preferredName":"Malignant Testicular Germ Cell Tumor Stage","preferredDefinition":"A malignant tumor predominantly affecting young men and often associated with cryptorchidism.  Seminoma is the most frequently seen malignant testicular germ cell tumor, followed by embryonal carcinoma and yolk sac tumor. -- 2004:Any distinct time period in a sequence of events.","longName":"C9063:C48308","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Testicular Germ Cell Tumor","conceptCode":"C9063","definition":"A malignant germ cell tumor that arises from the testis. It predominantly affects young men. Seminoma is the most frequently seen malignant testicular germ cell tumor, followed by embryonal carcinoma and yolk sac tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage","conceptCode":"C48308","definition":"Any distinct time period in a sequence of events.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A6A557F-FF22-CF56-E040-BB89AD431AD8","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-02","modifiedBy":"ONEDATA","dateModified":"2010-07-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A6A557F-FF33-CF56-E040-BB89AD431AD8","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-02","modifiedBy":"KUMMEROA","dateModified":"2012-04-20","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964899","version":"1","longName":"2022r1: Testicular / Germ Cell Cancer Pre-HSCT Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"tc_base_surg_test_stage","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedClinicalInterpretation:value","type":"HCT_BRIDG","context":"NHLBI"},{"name":"Alliance","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Specify the testicular cancer","type":"Preferred Question Text","description":"Specify the testicular cancer stage:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:3117210","type":"BRIDG Mapping Path","description":"PerformedDiagnosis > AssessedResultRelationship > PerformedObservation > PerformedClinicalInterpretation.value WHERE PerformedDiagnosis.value = \"testicular cancer\" AND PerformedObservation.methodCode = \"Rai Staging\" AND AssessedResultRelationship.typeCode = \"assess\"","url":null,"context":"NHLBI"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Testicular/retroperitoneal stage","url":null,"context":"Alliance"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A6A9C9C-0C5A-DC0E-E040-BB89AD435460","latestVersionIndicator":"Yes","beginDate":"2010-07-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-02","modifiedBy":"KUMMEROA","dateModified":"2021-08-10","changeDescription":". 2021-8-10 ak System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}